Compounds > n-(1-methyl-2-phenylethyl)adenosine
Page last updated: 2024-09-02

n-(1-methyl-2-phenylethyl)adenosine and dipyridamole

n-(1-methyl-2-phenylethyl)adenosine has been researched along with dipyridamole in 4 studies

Compound Research Comparison

Studies
(n-(1-methyl-2-phenylethyl)adenosine)		Trials
(n-(1-methyl-2-phenylethyl)adenosine)		Recent Studies (post-2010)
(n-(1-methyl-2-phenylethyl)adenosine)		Studies
(dipyridamole)		Trials
(dipyridamole)		Recent Studies (post-2010) (dipyridamole)
134047,826881632

Protein Interaction Comparison

ProteinTaxonomyn-(1-methyl-2-phenylethyl)adenosine (IC50)dipyridamole (IC50)
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)21.0682
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)21.0682
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)3.1233
Solute carrier family 22 member 2Homo sapiens (human)2.6
Multidrug resistance-associated protein 4Homo sapiens (human)5.15
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)2.6333
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)1.9708
3',5'-cyclic-AMP phosphodiesterase Sus scrofa (pig)5.835
Bile salt export pumpHomo sapiens (human)4
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)6.956
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.5
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.5
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.5
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)2.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.6333
Exopolyphosphatase PRUNE1Homo sapiens (human)0.78
Equilibrative nucleoside transporter 1Homo sapiens (human)0.0537
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)6.4

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peters, TJ; Shah, T; Simpson, RJ; Webster, AD1
Williams, EF1
Barlinski, J; Cano, E; Frossard, N; Lagente, V1
el-Ani, D; Jacobson, KA; Katz, A; Shainberg, A; Zimlichman, R1

Other Studies

4 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and dipyridamole

ArticleYear
Binding of adenosine and receptor-specific analogues to lymphocytes from control subjects and patients with common variable immunodeficiency.
    Clinical and experimental immunology, 1987, Volume: 69, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Agammaglobulinemia; Dipyridamole; Erythrocytes; Humans; Lymphocytes

1987
Plasticity of cardiovascular nucleoside transporters following chronic dipyridamole treatment.
    SAAS bulletin, biochemistry and biotechnology, 1997, Volume: 10

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Biological Transport; Brain; Cardiovascular System; Cell Membrane; Dipyridamole; Guinea Pigs; Kidney; Male; Myocardium; Nucleosides; Rats; Receptors, Purinergic P1; Thioinosine

1997
Adenosine reduces airway excitatory non-cholinergic (e-NC) contraction through both A1 and A2 adenosine receptor activation in the guinea pig.
    Fundamental & clinical pharmacology, 1997, Volume: 11, Issue:6

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Bronchi; Cholinergic Fibers; Dipyridamole; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance P; Theobromine; Vasodilator Agents; Xanthines

1997
Uptake of glucose analogs reflects the rate of contraction of cultured myocytes.
    Journal of basic and clinical physiology and pharmacology, 1999, Volume: 10, Issue:4

    Topics: 3-O-Methylglucose; Adenosine; Animals; Animals, Newborn; Carbachol; Cardiotonic Agents; Cells, Cultured; Deoxyglucose; Dipyridamole; Dose-Response Relationship, Drug; Glucose; Isoproterenol; Kinetics; Myocardial Contraction; Myocardium; Rats; Temperature; Time Factors; Vasodilator Agents

1999